tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Hims & Hers Health: Hold Rating Amid Mixed Financial Performance and Strategic Transition
PremiumRatingsHims & Hers Health: Hold Rating Amid Mixed Financial Performance and Strategic Transition
5d ago
Hims & Hers Health Reports Strong Q2 2025 Growth
Premium
Company Announcements
Hims & Hers Health Reports Strong Q2 2025 Growth
5d ago
Cautious Outlook for Hims & Hers Health Amid Revenue Shortfall and Adjusted Guidance
Premium
Ratings
Cautious Outlook for Hims & Hers Health Amid Revenue Shortfall and Adjusted Guidance
5d ago
Hims & Hers sees Q3 revenue $570M-$590M, consensus $584.1M
PremiumThe FlyHims & Hers sees Q3 revenue $570M-$590M, consensus $584.1M
6d ago
Hims & Hers affirms FY25 revenue $2.3B-$2.4B, consensus $2.35B
Premium
The Fly
Hims & Hers affirms FY25 revenue $2.3B-$2.4B, consensus $2.35B
6d ago
Hims and  Hers Health options imply 14.9% move in share price post-earnings
Premium
The Fly
Hims and Hers Health options imply 14.9% move in share price post-earnings
6d ago
Hims & Hers releases new data on GLP-1s
PremiumThe FlyHims & Hers releases new data on GLP-1s
12d ago
Hims & Hers Health: Hold Rating Amid Slowing Growth and Uncertain Prospects
Premium
Ratings
Hims & Hers Health: Hold Rating Amid Slowing Growth and Uncertain Prospects
12d ago
Lawmakers urge FDA to crack down on knockoff weight loss drugs, Bloomberg says
Premium
The Fly
Lawmakers urge FDA to crack down on knockoff weight loss drugs, Bloomberg says
13d ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100